Verastem Inc (VSTM)
11.89
+0.99
(+9.08%)
USD |
NASDAQ |
May 06, 16:00
11.61
-0.28
(-2.35%)
After-Hours: 20:00
Verastem SG&A Expense (Quarterly): 8.637M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.637M |
September 30, 2023 | 7.363M |
June 30, 2023 | 7.399M |
March 31, 2023 | 7.329M |
December 31, 2022 | 6.106M |
September 30, 2022 | 6.421M |
June 30, 2022 | 6.514M |
March 31, 2022 | 5.934M |
December 31, 2021 | 5.66M |
September 30, 2021 | 5.523M |
June 30, 2021 | 6.714M |
March 31, 2021 | 6.218M |
December 31, 2020 | 7.095M |
September 30, 2020 | 20.61M |
June 30, 2020 | 15.44M |
March 31, 2020 | 19.60M |
December 31, 2019 | 23.73M |
September 30, 2019 | 22.15M |
June 30, 2019 | 29.30M |
March 31, 2019 | 26.03M |
December 31, 2018 | 26.20M |
September 30, 2018 | 25.43M |
June 30, 2018 | 15.81M |
March 31, 2018 | 9.827M |
December 31, 2017 | 6.799M |
Date | Value |
---|---|
September 30, 2017 | 5.394M |
June 30, 2017 | 4.425M |
March 31, 2017 | 4.763M |
December 31, 2016 | 4.908M |
September 30, 2016 | 3.843M |
June 30, 2016 | 4.217M |
March 31, 2016 | 4.255M |
December 31, 2015 | 4.273M |
September 30, 2015 | 4.23M |
June 30, 2015 | 4.417M |
March 31, 2015 | 4.714M |
December 31, 2014 | 4.313M |
September 30, 2014 | 4.341M |
June 30, 2014 | 4.782M |
March 31, 2014 | 4.723M |
December 31, 2013 | 3.593M |
September 30, 2013 | 3.855M |
June 30, 2013 | 4.239M |
March 31, 2013 | 3.785M |
December 31, 2012 | 3.882M |
September 30, 2012 | 2.298M |
June 30, 2012 | 2.213M |
March 31, 2012 | 2.125M |
December 31, 2011 | 1.62M |
September 30, 2011 | 0.965M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
5.523M
Minimum
Sep 2021
29.30M
Maximum
Jun 2019
11.46M
Average
7.329M
Median
Mar 2023
SG&A Expense (Quarterly) Benchmarks
Johnson & Johnson | 5.057B |
Geron Corp | 27.06M |
Altimmune Inc | 4.332M |
Oragenics Inc | 1.754M |
Actinium Pharmaceuticals Inc | 2.962M |